The FDA issued a Class I recall of the TigerPaw II device Getinge (PINK:GETI B) subsidiary Maquet Cardiovascular acquired in 2013.
The recall, which affects some 4,154 of the TigerPaw II left atrial appendage closure devices, follows an increase in reports of torn tissue on the left atrial wall and bleeding during use of the device, the FDA said.
Help employers find you! Check out all the jobs and post your resume.
The recall, which affects some 4,154 of the TigerPaw II left atrial appendage closure devices, follows an increase in reports of torn tissue on the left atrial wall and bleeding during use of the device, the FDA said.
Help employers find you! Check out all the jobs and post your resume.
